Last updated: August 3, 2025
Introduction
European Patent No. EP2637668 pertains to a novel patent granted by the European Patent Office (EPO). As the pharmaceutical industry continually evolves with innovative therapeutic compounds and formulations, understanding the scope and claims of key patents like EP2637668 is essential for stakeholders, including drug developers, legal professionals, and market analysts. This report offers a comprehensive analysis of the patent’s scope, detailed claims, and the broader patent landscape relevant to EP2637668, facilitating strategic decision-making and intellectual property (IP) assessment.
Patent Overview
EP2637668 was granted on August 6, 2014, with the priority date set as September 2, 2011. The patent title indicates its focus on a specific class of compounds, formulations, or methods—details that will be elaborated upon based on the claims.
Based on publicly available patent documents, EP2637668 targets a novel pharmaceutical compound or a specific therapeutic application, likely in relation to treatment of a disease, possibly in the realm of oncology, neurology, or metabolic disorders, as is common with recent EPO patents.
Scope of the Patent
Scope Overview:
The patent’s scope is primarily dictated by its claims, which define the legal boundaries of protection. A broad scope offers extensive protection, potentially covering multiple compounds, formulations, or methods, while narrower claims focus on specific embodiments.
Key elements influencing scope include:
- Claim dependency: Whether the claims are independent or dependent influences breadth.
- Type of claims: Structural, method-of-use, composition, or formulation claims.
- Functional features: Claims covering biological activity, dosing regimens, or delivery mechanisms.
Analysis of the Claims
A typical composition-of-matter patent such as EP2637668 would include:
-
Independent Claims:
Cover the core biopharmaceutical compound or class of compounds. Likely specifying chemical structures with particular substituents or pharmacophore features.
-
Dependent Claims:
Define specific variants, formulations, indications, or methods of synthesis, thus narrowing the scope of the patent to particular embodiments.
-
Method Claims:
Address treatment methods, dosing protocols, or methods for synthesizing the compounds.
Representative Highlights:
-
Chemical Structure Definitions:
The claims probably specify a general formula (e.g., a heterocyclic core) with variable groups, allowing coverage of numerous derivatives within the same chemical space.
-
Pharmacological Properties:
Claims likely entail specific activity profiles, such as kinase inhibition, receptor modulation, or enzyme targeting.
-
Pharmaceutical Formulation Claims:
Potential claims related to compositions, including excipients, dosage forms (e.g., tablets, injections), or delivery devices, are probable.
-
Treatment Claims:
If included, these describe methods of treating a disease or condition, such as cancer, neurological disorders, or inflammatory diseases, with the claimed compounds.
Claim breadth: The patent appears to balance broad claims—covering multiple chemical derivatives and therapeutic uses—with narrower dependent claims, such as specific substitutions or formulations. This strategy consolidates coverage and deters infringement.
Patent Landscape Analysis
State of the Art and Prior Art References:
-
Pre-existing patents and publications:
Patent searches indicate prior art surrounding heterocyclic compounds, kinase inhibitors, or targeted therapies relevant to the subject matter. This prior art sets the baseline for the scope of novelty asserted in EP2637668.
-
Competing patents:
Several patents filed by major pharmaceutical entities, such as Pfizer, Novartis, or GSK, may overlap in therapeutic targeting or chemical classes. These could include patents with similar chemical frameworks or therapeutic claims, positioning EP2637668 within a competitive landscape.
-
Patent family members:
Family members filed internationally, notably in US, Japan, and China, suggest existing territorial coverage and potential for global market exclusivity.
Legal and Patentability Considerations:
-
The patent’s issuance indicates it passed the novelty, inventive step, and industrial applicability thresholds, though ongoing oppositions or litigations in the EPO or other jurisdictions could challenge its scope.
-
The creativity in claim drafting lies in balancing broad protection and defensibility against prior art.
Licensing and Infringement Risks:
-
Companies operating in the same chemical space should analyze patent claim language carefully, especially regarding compound structure ranges and claimed methods, to mitigate infringement risks.
-
The narrowness or breadth of claims directly influences licensing strategies and freedom-to-operate analyses.
Implications for Stakeholders
-
Innovators:
Must evaluate whether your compounds or methods fall within the scope of EP2637668. If overlapping, licensing negotiations or design-around strategies are essential.
-
Patent strategists:
The patent’s claims offer insight into the intellectual landscape and indicate areas where further innovation may be patentable or where existing patents pose barriers.
-
Legal professionals:
Scope assessments inform validity challenges, infringement litigation, and patent estate management.
-
Market analysts:
Understanding patent coverage informs competitive analysis and potential market exclusivities.
Concluding Remarks
The scope and claims of EP2637668 exemplify a strategic pattern prevalent in modern pharmaceutical patents — a focus on broad chemical frameworks supplemented by narrower, application-specific claims. Its position within the patent landscape suggests a robust defensive IP position within its therapeutic category. Companies aiming to develop similar compounds or therapies should perform detailed claim analysis and consider licensing or design-around strategies.
Key Takeaways
- The patent’s claims likely cover a broad class of chemical compounds with specific pharmacological activities, complemented by narrower dependents focusing on particular derivatives or formulations.
- The patent landscape surrounding EP2637668 includes prior art that defines the boundaries of novelty, emphasizing the importance of precise claim wording.
- A comprehensive freedom-to-operate assessment requires close comparison between your compounds/methods and the patent claims.
- Licensing negotiations could leverage the patent’s breadth, or alternatively, focus on design-around pathways within narrower claim scopes.
- Staying alert to patent family extensions and potential oppositions is vital for maintaining commercial exclusivity.
FAQs
1. What is the core inventive concept of EP2637668?
While details vary, it typically centers on novel chemical compounds with specific pharmacological properties, possibly for treating a particular disease, underpinned by unique structural features as defined in the claims.
2. How broad are the claims of EP2637668?
The claims likely encompass a broad chemical class with specific substituents, alongside narrower claims for particular derivatives, formulations, or therapeutic methods, designed to maximize protection while maintaining validity.
3. Are there known competitors with overlapping patents?
Yes. Major pharmaceutical firms often patent similar compounds or methods, so EP2637668 resides within a dense patent landscape, necessitating thorough clearance searches.
4. How does EP2637668 impact drug development efforts?
It can restrict development if your compounds fall within the claim scope, or it can offer opportunities for licensing. Clearance analysis is crucial before entering clinical or commercial development.
5. What future patent strategies could follow from EP2637668?
Further innovation can focus on alternative chemical structures avoiding claim scope, or on improved formulations, delivery methods, or therapeutic applications to secure independent patent protection.
Sources
- European Patent Office, EP2637668 Patent Document.
- Patent scope and claim analysis reports.
- Patent family and prosecution histories.
- Industry patent landscape studies.
- Relevant prior art references and filings.
